Cargando…
Predictive features of ligand‐specific signaling through the estrogen receptor
Some estrogen receptor‐α (ERα)‐targeted breast cancer therapies such as tamoxifen have tissue‐selective or cell‐specific activities, while others have similar activities in different cell types. To identify biophysical determinants of cell‐specific signaling and breast cancer cell proliferation, we...
Autores principales: | Nwachukwu, Jerome C, Srinivasan, Sathish, Zheng, Yangfan, Wang, Song, Min, Jian, Dong, Chune, Liao, Zongquan, Nowak, Jason, Wright, Nicholas J, Houtman, René, Carlson, Kathryn E, Josan, Jatinder S, Elemento, Olivier, Katzenellenbogen, John A, Zhou, Hai‐Bing, Nettles, Kendall W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848761/ https://www.ncbi.nlm.nih.gov/pubmed/27107013 http://dx.doi.org/10.15252/msb.20156701 |
Ejemplares similares
-
Triaryl-Substituted Schiff
Bases Are High-Affinity
Subtype-Selective Ligands for the Estrogen Receptor
por: Liao, Zong-Quan, et al.
Publicado: (2014) -
OR12-07 Full Antagonism of Breast Cancer Cell Proliferation Can Result from Many Ligand-Induced Conformational Distortions of the Estrogen Receptor Ligand Binding Domain
por: Nwachukwu, Jerome, et al.
Publicado: (2020) -
Ligand-binding dynamics rewire cellular signaling via Estrogen Receptor-α
por: Srinivasan, Sathish, et al.
Publicado: (2013) -
Full Antagonism of the Estrogen Receptor without a Prototypical Ligand Side Chain
por: Srinivasan, Sathish, et al.
Publicado: (2016) -
Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network
por: Nwachukwu, Jerome C, et al.
Publicado: (2014)